BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1482761)

  • 1. Blockade of natural and neuropeptide Y-induced carbohydrate feeding by a receptor antagonist PYX-2.
    Leibowitz SF; Xuereb M; Kim T
    Neuroreport; 1992 Nov; 3(11):1023-6. PubMed ID: 1482761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of neuropeptide Y-induced feeding: dissociation of Y1 and Y2 receptor effects on natural meal patterns.
    Leibowitz SF; Alexander JT
    Peptides; 1991; 12(6):1251-60. PubMed ID: 1667688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y projection from arcuate nucleus to parvocellular division of paraventricular nucleus: specific relation to the ingestion of carbohydrate.
    Jhanwar-Uniyal M; Beck B; Jhanwar YS; Burlet C; Leibowitz SF
    Brain Res; 1993 Dec; 631(1):97-106. PubMed ID: 8298999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of neuropeptide Y (NPY)-induced feeding and c-Fos response in magnocellular paraventricular nucleus by a NPY receptor antagonist: a site of NPY action.
    Yokosuka M; Kalra PS; Kalra SP
    Endocrinology; 1999 Oct; 140(10):4494-500. PubMed ID: 10499503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for neuropeptide Y mediation of eating produced by food deprivation and for a variant of the Y1 receptor mediating this peptide's effect.
    Stanley BG; Magdalin W; Seirafi A; Nguyen MM; Leibowitz SF
    Peptides; 1992; 13(3):581-7. PubMed ID: 1326105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Agmatine in the hypothalamic paraventricular nucleus stimulates feeding in rats: involvement of neuropeptide Y.
    Taksande BG; Kotagale NR; Nakhate KT; Mali PD; Kokare DM; Hirani K; Subhedar NK; Chopde CT; Ugale RR
    Br J Pharmacol; 2011 Sep; 164(2b):704-18. PubMed ID: 21564088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic paraventricular 5-hydroxytryptamine: receptor-specific inhibition of NPY-stimulated eating and energy metabolism.
    Currie PJ; Coiro CD; Niyomchai T; Lira A; Farahmand F
    Pharmacol Biochem Behav; 2002 Apr; 71(4):709-16. PubMed ID: 11888562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a galanin antagonist on exogenous galanin and natural patterns of fat ingestion.
    Leibowitz SF; Kim T
    Brain Res; 1992 Dec; 599(1):148-52. PubMed ID: 1283559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropeptide Y functions as a physiologic regulator of cephalic phase acid secretion.
    Lee MC; Lawson DC; Pappas TN
    Regul Pept; 1994 Aug; 52(3):227-34. PubMed ID: 7800854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoid receptors in PVN: interactions with NE, NPY, and Gal in relation to feeding.
    Tempel DL; Leibowitz SF
    Am J Physiol; 1993 Nov; 265(5 Pt 1):E794-800. PubMed ID: 7694500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
    Kask A; Rägo L; Harro J
    Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anorexic action of a new potential neuropeptide Y antagonist [D-Tyr27,36, D-Thr32]-NPY (27-36) infused into the hypothalamus of the rat.
    Myers RD; Wooten MH; Ames CD; Nyce JW
    Brain Res Bull; 1995; 37(3):237-45. PubMed ID: 7627566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Putative neuropeptide Y antagonist failed to decrease overeating in obese Zucker rats.
    Beck B; Stricker-Krongrad A; Musse N; Nicolas JP; Burlet C
    Neurosci Lett; 1994 Nov; 181(1-2):126-8. PubMed ID: 7898751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of the hypothalamic paraventricular nucleus and central nucleus of the amygdala in naloxone blockade of neuropeptide Y-induced feeding revealed by c-fos expression.
    Pomonis JD; Levine AS; Billington CJ
    J Neurosci; 1997 Jul; 17(13):5175-82. PubMed ID: 9185555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y in relation to carbohydrate intake, corticosterone and dietary obesity.
    Wang J; Akabayashi A; Dourmashkin J; Yu HJ; Alexander JT; Chae HJ; Leibowitz SF
    Brain Res; 1998 Aug; 802(1-2):75-88. PubMed ID: 9748512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Orexin-A signaling in the paraventricular nucleus modulates spontaneous firing of glucose-sensitive neurons and promotes food intake via the NPY pathway in rats.
    Wang C; Han X; Guo F; Sun X; Luan X; Xu L
    Biochem Biophys Res Commun; 2018 Oct; 505(1):162-167. PubMed ID: 30243725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y receptor agonists: multiple effects on spontaneous activity in the paraventricular hypothalamus.
    Aramakis VB; Stanley BG; Ashe JH
    Peptides; 1996; 17(8):1349-57. PubMed ID: 8971931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine and its withdrawal alter feeding induced by paraventricular hypothalamic injections of neuropeptide Y in Sprague-Dawley rats.
    Bishop C; Parker GC; Coscina DV
    Psychopharmacology (Berl); 2002 Jul; 162(3):265-72. PubMed ID: 12122484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociated feeding and hypothermic effects of neuropeptide Y in the paraventricular and perifornical hypothalamus.
    Currie PJ; Coscina DV
    Peptides; 1995; 16(4):599-604. PubMed ID: 7479290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of PVN galanin on macronutrient selection.
    Tempel DL; Leibowitz KJ; Leibowitz SF
    Peptides; 1988; 9(2):309-14. PubMed ID: 2453854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.